Jami M. Mandelin
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies.
Journal: Scientific reports
Published: November 16, 2024
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.
Journal: Cell reports. Medicine
Published: April 19, 2023
Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 18, 2023
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practice.
Journal: Journal of cancer research and clinical oncology
Published: January 24, 2023
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 18, 2022
Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers.
Journal: Molecular cancer therapeutics
Published: October 11, 2021
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3.
Journal: Rheumatology (Oxford, England)
Published: October 01, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 16, 2020
DEC2 Blocks the Effect of the ARNTL2/NPAS2 Dimer on the Expression of PER3 and DBP.
Journal: Journal of circadian rhythms
Published: September 14, 2018
Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1β and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis.
Journal: PloS one
Published: February 04, 2015
Neutrophils produce interleukin-17B in rheumatoid synovial tissue.
Journal: Rheumatology (Oxford, England)
Published: September 24, 2013
Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthma.
Journal: PloS one
Published: November 08, 2012
Last Updated: 09/26/2026